• Submit your abstract for the Imaging in the Eye conference by Wed., Mar. 1. Learn more
  • Complete the new Research Essentials training series, developed by members for ARVO’s Online Education program. Learn more
  • Purchase your recording of the NEI/FDA Endpoints: AMD and inherited retinal diseases. View here
  • Have you seen ARVO’s series of OCT videos highlighting how the technology moved from the lab to quietly revolutionizing eye care around the world? View here
  • IOVS Special Issue on the 25th anniversary of optical coherence tomography released. More than 70 papers highlight the versatility and the impact of technology. Read more
  • The ARVO Foundation offers authors financial support through the ARVO Publications Grant. Authors must apply for the grant before they submit their manuscript. Learn more

Special Issue: Call for Papers

Biomarkers and Surrogate Endpoints in Ophthalmic Clinical Research

Complemented by invited papers covering glaucoma, dry eye, retinal diseases and omics, along with regulatory perspectives, submitted manuscripts should be original hypothesis-driven research, meta-analyses and reviews focused on the use of biomarkers and surrogate endpoints in ophthalmic clinical research and care, with particular attention to scientific advances (proposal of new biomarkers), biomarkers validation and identification. Included biomarkers might be biochemical, molecular (omics), clinical (including patient reported, symptoms, function and objective signs) and imaging.
Special guest editors for this issue are ARVO members Edoardo Villani, MD, University of Milan, and Stela Vujosevic, MD, PhD, University of Padua, who organized a successful Special Interest Group Session on this topic at the 2016 ARVO Annual Meeting.
Submit your manuscript by March 1, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.